Clayton Rowland

712 total citations
9 papers, 560 citations indexed

About

Clayton Rowland is a scholar working on Clinical Psychology, Pharmacology and General Health Professions. According to data from OpenAlex, Clayton Rowland has authored 9 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Psychology, 2 papers in Pharmacology and 2 papers in General Health Professions. Recurrent topics in Clayton Rowland's work include Obsessive-Compulsive Spectrum Disorders (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Eating Disorders and Behaviors (2 papers). Clayton Rowland is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Eating Disorders and Behaviors (2 papers). Clayton Rowland collaborates with scholars based in United States, Germany and New Zealand. Clayton Rowland's co-authors include Dan J. Stein, Jee Hyun Kwon, James Broatch, Carol Himelein, Albert I. Wertheimer, J. Lyle Bootman, Darwin E. Zaske, Eric Hollander, Cheryl M. Wong and Robert G. Holloway and has published in prestigious journals such as Social Science & Medicine, Journal of Pharmaceutical Sciences and PharmacoEconomics.

In The Last Decade

Clayton Rowland

9 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clayton Rowland United States 9 359 140 122 79 65 9 560
W. Gaebel Germany 10 178 0.5× 34 0.2× 65 0.5× 431 5.5× 52 0.8× 33 542
Robert Arbuckle United Kingdom 10 89 0.2× 91 0.7× 169 1.4× 97 1.2× 20 0.3× 23 512
Rafael A. Rivas-Vazquez United States 9 113 0.3× 73 0.5× 50 0.4× 128 1.6× 28 0.4× 46 313
S Pirzada Sattar United States 11 99 0.3× 45 0.3× 42 0.3× 132 1.7× 63 1.0× 24 390
Morgane Rousselet France 12 128 0.4× 58 0.4× 56 0.5× 64 0.8× 29 0.4× 36 379
Martin G. Livingston United Kingdom 10 184 0.5× 45 0.3× 75 0.6× 243 3.1× 60 0.9× 12 553
Fernando Cañas Spain 15 127 0.4× 54 0.4× 43 0.4× 317 4.0× 32 0.5× 29 478
Donald M. Gallant United States 13 91 0.3× 31 0.2× 34 0.3× 203 2.6× 54 0.8× 78 535
Joan M. Anzia United States 8 208 0.6× 35 0.3× 38 0.3× 418 5.3× 48 0.7× 16 701
Martina Novi Italy 9 75 0.2× 112 0.8× 43 0.4× 87 1.1× 28 0.4× 17 337

Countries citing papers authored by Clayton Rowland

Since Specialization
Citations

This map shows the geographic impact of Clayton Rowland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clayton Rowland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clayton Rowland more than expected).

Fields of papers citing papers by Clayton Rowland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clayton Rowland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clayton Rowland. The network helps show where Clayton Rowland may publish in the future.

Co-authorship network of co-authors of Clayton Rowland

This figure shows the co-authorship network connecting the top 25 collaborators of Clayton Rowland. A scholar is included among the top collaborators of Clayton Rowland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clayton Rowland. Clayton Rowland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Venditti, Laura, et al.. (2000). The impact of antidepressant use on social functioning: reboxetine versus fluoxetine. International Clinical Psychopharmacology. 15(5). 279–289. 20 indexed citations
2.
Hoerger, Thomas J., et al.. (1998). Cost Effectiveness of Pramipexole in Parkinson??s Disease in the US. PharmacoEconomics. 14(5). 541–557. 39 indexed citations
3.
Hollander, Eric, Dan J. Stein, Jee Hyun Kwon, et al.. (1998). Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder. CNS Spectrums. 3(S1). 48–58. 42 indexed citations
4.
Hollander, Eric, Dan J. Stein, Jee Hyun Kwon, et al.. (1997). Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder. CNS Spectrums. 2(10). 16–25. 101 indexed citations
5.
Yelin, Edward, et al.. (1996). The impact on employment of an intervention to increase recognition of previously untreated anxiety among primary care physicians. Social Science & Medicine. 42(7). 1069–1075. 14 indexed citations
6.
Kwon, Jee Hyun, et al.. (1996). Obsessive-compulsive and spectrum disorders: overview and quality of life issues.. PubMed. 57 Suppl 8. 3–6. 249 indexed citations
7.
Bootman, J. Lyle, Albert I. Wertheimer, Darwin E. Zaske, & Clayton Rowland. (1979). Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis. Journal of Pharmaceutical Sciences. 68(3). 267–272. 74 indexed citations
8.
Bootman, J. Lyle, Darwin E. Zaske, Albert I. Wertheimer, & Clayton Rowland. (1979). Cost of individualizing aminoglycoside dosage regimens. American Journal of Health-System Pharmacy. 36(3). 368–370. 12 indexed citations
9.
Bootman, J. Lyle, Clayton Rowland, & Albert I. Wertheimer. (1979). Cost-Benefit Analysis. Evaluation & the Health Professions. 2(2). 129–154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026